Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brust

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Emerging Infectious Diseases|February 26, 2014
Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South AfricaNeel R Gandhi, James C M Brust, Prashini Moodley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2012
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosisKelly E Dooley, Carole D Mitnick, Mary Ann DeGroote, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2021
Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant TuberculosisMahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, et al.
Plos One|July 13, 2017
Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South AfricaMatthew J Magee, Yan V Sun, James C M Brust, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant TuberculosisMark Bateman, Allison Wolf, Benjamin Chimukangara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2019
The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse EventsJonathan P Smith, Neel R Gandhi, N Sarita Shah, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2020
Clofazimine pharmacokinetics in patients with TB: dosing implicationsMahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, et al.
Plos One|October 14, 2017
Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South AfricaThandi Kapwata, Natashia Morris, Angela Campbell, et al.
Emerging Infectious Diseases|February 22, 2017
pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and GeorgiaSalim Allana, Elena Shashkina, Barun Mathema, et al.
Open Forum Infectious Diseases|August 31, 2022
Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline TreatmentStijn W van Beek, Lénaïg Tanneau, Graeme Meintjes, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Emerging Infectious Diseases|February 26, 2014
Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South AfricaNeel R Gandhi, James C M Brust, Prashini Moodley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2012
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosisKelly E Dooley, Carole D Mitnick, Mary Ann DeGroote, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2021
Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant TuberculosisMahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, et al.
Plos One|July 13, 2017
Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South AfricaMatthew J Magee, Yan V Sun, James C M Brust, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant TuberculosisMark Bateman, Allison Wolf, Benjamin Chimukangara, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2019
The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse EventsJonathan P Smith, Neel R Gandhi, N Sarita Shah, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2020
Clofazimine pharmacokinetics in patients with TB: dosing implicationsMahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, et al.
Plos One|October 14, 2017
Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South AfricaThandi Kapwata, Natashia Morris, Angela Campbell, et al.
Emerging Infectious Diseases|February 22, 2017
pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and GeorgiaSalim Allana, Elena Shashkina, Barun Mathema, et al.
Open Forum Infectious Diseases|August 31, 2022
Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline TreatmentStijn W van Beek, Lénaïg Tanneau, Graeme Meintjes, et al.
Pageof 11